DOI: 10.1055/s-00000069

Seminars in Liver Disease

Issue 03 · Volume 37 · August 2017 DOI: 10.1055/s-007-34675

Review Article

  • 189
    Krenkel, Oliver; Tacke, Frank:

    Macrophages in Nonalcoholic Fatty Liver Disease: A Role Model of Pathogenic Immunometabolism

  • 198
    Male, Victoria; Stegmann, Kerstin A.; Easom, Nicholas J.; Maini, Mala K.:

    Natural Killer Cells in Liver Disease

  • 210
    Heikenwälder, Mathias; Pikarsky, Eli:

    Learning the Roles of the Hepatic Adaptive Immune System in Hepatocellular Carcinoma—Nature's Guide for Successful Cancer Immunotherapy

  • 219
    Massey, Veronica; Cabezas, Joaquin; Bataller, Ramon:

    Epigenetics in Liver Fibrosis

  • 231
    Testoni, Barbara; Levrero, Massimo; Zoulim, Fabien:

    Challenges to a Cure for HBV Infection

  • 243
    Van Beers, Bernard E.; Garteiser, Philippe; Leporq, Benjamin; Rautou, Pierre-Emmanuel; Valla, Dominique:

    Quantitative Imaging in Diffuse Liver Diseases

  • 259
    Kambadakone, Avinash; Baliyan, Vinit; Zhu, Andrew X.:

    Functional Imaging and Assessment of Antitumor Activity in Systemic Therapy for Hepatocellular Carcinoma

  • 275
    Torres, Ferran; Ríos, José; Saez-Peñataro, Joaquín; Pontes, Caridad:

    Is Propensity Score Analysis a Valid Surrogate of Randomization for the Avoidance of Allocation Bias?